FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076446101> ?p ?o ?g. }

• W2076446101 endingPage "55" @default.
• W2076446101 startingPage "47" @default.
• W2076446101 abstract "1 The modulatory effects of agonists and antagonists of prejunctional α 2 ‐adrenoceptors on the electrical field stimulation (EFS, 0.3 ms, 12 V)‐induced release of endogenous noradrenaline (NA) and the cotransmitter adenosine 5′ triphosphate (ATP) were measured in endothelium‐denuded segments of canine inferior mesenteric artery and compared with effects in mesenteric vein. The overflow of NA and ATP was evoked by long‐duration (2 min) EFS at low frequency (4 Hz) and high frequency (16 Hz) of stimulation and was analysed using HPLC techniques with electrochemical detection and fluorescence detection, respectively. 2 The EFS‐evoked overflow of both NA and ATP was significantly reduced by tetrodotoxin (1 μ M ) and guanethidine (10 μ M ) in the artery and vein. Desipramine (10 μ M ), a blocker of neuronal uptake of NA, increased the EFS (4 and 16 Hz)‐evoked overflow of NA in both artery and vein. EFS‐evoked overflow of NA in vein exceeded the NA overflow in artery at both 4 and 16 Hz in control preparations as well as in the presence of desipramine. However, the EFS‐evoked overflow of ATP was equal in the artery and vein. 3 Stimulation of α 2 ‐adrenoceptors with clonidine (0.1 μ M ) and oxymethazoline (0.3 μ M ) reduced the EFS evoked overflow of NA in both artery and vein at 4 Hz, whereas the NA overflow at 16 Hz remained unchanged in both blood vessels. The overflow of ATP as well as of ADP (and hence ATP:ADP ratio) was unaffected by the α 2 ‐adrenoceptor agonists in the artery and vein. 4 In artery, blockade of α 2 ‐adrenoceptors with yohimbine at a concentration of 0.1 μ M caused no effect on the NA overflow neither at 4 Hz nor at 16 Hz of EFS. Yohimbine at a concentration of 1 μ M increased the overflow of NA at 4 Hz but not 16 Hz of EFS. In vein, however, yohimbine (0.1 and 1 μ M ) increased NA overflow at both 4 and 16 Hz of stimulation. Idazoxan (1 μ M ) increased the NA overflow in artery only at 4 Hz, whereas in vein idazoxan increased the NA overflow at both 4 and 16 Hz. No changes of EFS‐evoked ATP overflow were observed in the presence of 0.1 μ M yohimbine in both artery and vein. Greater concentration of yohimbine (i.e. 1 μ M ) increased the overflow of ATP in both the artery and vein only at 4 Hz EFS. Idazoxan (1 μ M ) enhanced the ATP overflow only at 16 Hz in vein. The overflow of ADP was affected by both yohimbine and idazoxan in a similar manner to the ATP overflow so that the ATP:ADP ratios were not changed. 5 In conclusion, sympathetic nerves in both mesenteric arteries and veins appear to release ATP along with NA. Release of NA in veins exceeds release of NA in arteries, whereas both the canine artery and vein release equal amount of ATP. At long‐duration nerve stimulation (as might occur during stress) the α 2 ‐adrenoceptors appear to rather modulate release of NA than release of the cotransmitter ATP. The prejunctional autoinhibition of NA release is more effective at lower frequencies of nerve stimulation. The α 2 ‐adrenoceptor‐mediated neuromodulation plays a greater role in veins than arteries. Quantitative differences in α 2 ‐adrenoceptor‐mediated neuromodulation in the arteries and veins may participate to differing contributions of mesenteric blood vessels to the control of blood flow and volume distribution in splanchnic circulation." @default.
• W2076446101 created "2016-06-24" @default.
• W2076446101 creator A5012282460 @default.
• W2076446101 creator A5036914859 @default.
• W2076446101 date "2001-02-10" @default.
• W2076446101 modified "2023-10-18" @default.
• W2076446101 title "Presynaptic alpha2-adrenoceptor-mediated modulation of adenosine 5' triphosphate and noradrenaline corelease: differences in canine mesenteric artery and vein" @default.
• W2076446101 cites W1531423968 @default.
• W2076446101 cites W1595326866 @default.
• W2076446101 cites W1965065010 @default.
• W2076446101 cites W1985989203 @default.
• W2076446101 cites W1987698326 @default.
• W2076446101 cites W1994175587 @default.
• W2076446101 cites W1994387111 @default.
• W2076446101 cites W2039321923 @default.
• W2076446101 cites W2046153118 @default.
• W2076446101 cites W2055272286 @default.
• W2076446101 cites W2064211997 @default.
• W2076446101 cites W2080604199 @default.
• W2076446101 cites W2085857904 @default.
• W2076446101 cites W2086915061 @default.
• W2076446101 cites W2090319769 @default.
• W2076446101 cites W2092183051 @default.
• W2076446101 cites W2092644721 @default.
• W2076446101 cites W2094485168 @default.
• W2076446101 cites W2106612423 @default.
• W2076446101 cites W2115519984 @default.
• W2076446101 cites W2116045140 @default.
• W2076446101 cites W2132302523 @default.
• W2076446101 cites W2159876288 @default.
• W2076446101 cites W3027911073 @default.
• W2076446101 cites W4206771055 @default.
• W2076446101 cites W4212792929 @default.
• W2076446101 doi "https://doi.org/10.1046/j.1365-2680.2001.00207.x" @default.
• W2076446101 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11422578" @default.
• W2076446101 hasPublicationYear "2001" @default.
• W2076446101 type Work @default.
• W2076446101 sameAs 2076446101 @default.
• W2076446101 citedByCount "33" @default.
• W2076446101 countsByYear W20764461012013 @default.
• W2076446101 countsByYear W20764461012014 @default.
• W2076446101 countsByYear W20764461012015 @default.
• W2076446101 countsByYear W20764461012023 @default.
• W2076446101 crossrefType "journal-article" @default.
• W2076446101 hasAuthorship W2076446101A5012282460 @default.
• W2076446101 hasAuthorship W2076446101A5036914859 @default.
• W2076446101 hasConcept C126322002 @default.
• W2076446101 hasConcept C134018914 @default.
• W2076446101 hasConcept C185592680 @default.
• W2076446101 hasConcept C24998067 @default.
• W2076446101 hasConcept C2776232365 @default.
• W2076446101 hasConcept C2776820930 @default.
• W2076446101 hasConcept C2777202286 @default.
• W2076446101 hasConcept C2779177272 @default.
• W2076446101 hasConcept C2780250439 @default.
• W2076446101 hasConcept C2781161787 @default.
• W2076446101 hasConcept C42219234 @default.
• W2076446101 hasConcept C71924100 @default.
• W2076446101 hasConceptScore W2076446101C126322002 @default.
• W2076446101 hasConceptScore W2076446101C134018914 @default.
• W2076446101 hasConceptScore W2076446101C185592680 @default.
• W2076446101 hasConceptScore W2076446101C24998067 @default.
• W2076446101 hasConceptScore W2076446101C2776232365 @default.
• W2076446101 hasConceptScore W2076446101C2776820930 @default.
• W2076446101 hasConceptScore W2076446101C2777202286 @default.
• W2076446101 hasConceptScore W2076446101C2779177272 @default.
• W2076446101 hasConceptScore W2076446101C2780250439 @default.
• W2076446101 hasConceptScore W2076446101C2781161787 @default.
• W2076446101 hasConceptScore W2076446101C42219234 @default.
• W2076446101 hasConceptScore W2076446101C71924100 @default.
• W2076446101 hasIssue "1" @default.
• W2076446101 hasLocation W20764461011 @default.
• W2076446101 hasLocation W20764461012 @default.
• W2076446101 hasOpenAccess W2076446101 @default.
• W2076446101 hasPrimaryLocation W20764461011 @default.
• W2076446101 hasRelatedWork W1559721762 @default.
• W2076446101 hasRelatedWork W2008455203 @default.
• W2076446101 hasRelatedWork W2031841751 @default.
• W2076446101 hasRelatedWork W2064753718 @default.
• W2076446101 hasRelatedWork W2357990663 @default.
• W2076446101 hasRelatedWork W2360477194 @default.
• W2076446101 hasRelatedWork W2384919234 @default.
• W2076446101 hasRelatedWork W2397351514 @default.
• W2076446101 hasRelatedWork W2417727910 @default.
• W2076446101 hasRelatedWork W4240908125 @default.
• W2076446101 hasVolume "21" @default.
• W2076446101 isParatext "false" @default.
• W2076446101 isRetracted "false" @default.
• W2076446101 magId "2076446101" @default.
• W2076446101 workType "article" @default.